125
Participants
Start Date
January 31, 2005
Primary Completion Date
January 31, 2006
Study Completion Date
January 31, 2006
GW873140
Combivir
GSK Investigational Site, Brussels
GSK Investigational Site, Newark
GSK Investigational Site, New York
GSK Investigational Site, Rochester
GSK Investigational Site, Philadelphia
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Milan
GSK Investigational Site, Milan
GSK Investigational Site, Brescia
GSK Investigational Site, Madrid
GSK Investigational Site, Conyers
GSK Investigational Site, Tarzana
GSK Investigational Site, Hanover
GSK Investigational Site, Orlando
GSK Investigational Site, Vero Beach
GSK Investigational Site, Miami
GSK Investigational Site, Tampa
GSK Investigational Site, Nantes
GSK Investigational Site, Minneapolis
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Chicago
GSK Investigational Site, Lyon
GSK Investigational Site, Paris
GSK Investigational Site, Dallas
GSK Investigational Site, Dallas
GSK Investigational Site, Dallas
GSK Investigational Site, Denver
GSK Investigational Site, Las Vegas
GSK Investigational Site, Los Angeles
GSK Investigational Site, Los Angeles
GSK Investigational Site, Beverly Hills
GSK Investigational Site, Levallois-Perret
GSK Investigational Site, Bakersfield
GSK Investigational Site, San Francisco
GSK Investigational Site, Stanford
GSK Investigational Site, Würzburg
GSK Investigational Site, Portland
GSK Investigational Site, Boston
GSK Investigational Site, Providence
GSK Investigational Site, Ottawa
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
GSK Investigational Site, Montreal
GSK Investigational Site, Coimbra
GSK Investigational Site, Lisbon
GSK Investigational Site, Porto
GSK Investigational Site, Manchester
GSK Investigational Site, Brighton
GSK Investigational Site, Birmingham
GSK Investigational Site, London
GSK Investigational Site, London
Lead Sponsor
ViiV Healthcare
INDUSTRY